<DOC>
	<DOC>NCT02578693</DOC>
	<brief_summary>The study is designed to provide long term clinical and virologic follow up in subjects infected with hepatitis C virus (HCV) who received interferon-based therapy or direct-acting antiviral agents (DAAs)-based therapy. This long term follow up study is observational and no treatment is provided for HCV infection.</brief_summary>
	<brief_title>Follow up of IFN Vs DAAs HCV SVR (IFDACS Study)</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<criteria>Patients with chronic hepatitis C treated with interferonbased therapy or directacting agents (DAAs)based regimen; Provide written, informed consent; Be willing and able to comply with the visit schedule and protocolmandated procedures. Individuals planning to start a new course of hepatitis C therapy including any investigational drug or device during the course of the followup time frame; History of clinically significant illness or any other major medical disorder that may interfere with follow up, assessments, or compliance with the protocol. Inability to provide written informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>